Fiera Apex, an asset manager, emphasizes the importance of identifying high-quality small and mid-cap companies with strong management teams and sustainable competitive advantages for investors. The healthcare and technology sectors offer potential for high growth and manageable risk.
In the healthcare sector, driven by innovation, demographic trends, and solid fundamentals, small and mid-cap companies present significant long-term growth potential. In biotechnology, opportunities exist in companies focused on addressing unmet medical needs with de-risked clinical assets and substantial upside potential in the market.
Prescription drug spending in the U.S. exceeds $400 billion yearly, with vast untapped markets awaiting solutions. Small and mid-cap biotech companies are poised to make breakthroughs in addressing major diseases and rare conditions.
In the technology sector, small and mid-cap firms focus on cloud computing, artificial intelligence, and digital transformation. Opportunities in AI exist in companies processing complex data, while cloud computing offers possibilities for modern platforms and data integration in industries like construction and public administration.
Fiera Apex experts highlight the potential for companies in these sectors to seize opportunities in the evolving market landscape, providing investors with a chance to capitalize on the growth potential of small and mid-cap firms with strong management and competitive advantages.
Source
Photo credit www.fundssociety.com